搜索临床试验以:Immunotherapy, Adoptive
总计326个结果
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); ImmunityBio, Inc.; The V Foundation...招聘中
-
National Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)主动,不招人滤泡性淋巴瘤 | 急性淋巴细胞白血病 | 急性淋巴细胞白血病 | 非霍奇金淋巴瘤 | 球 | 全部 | 大细胞淋巴瘤 | B型非霍奇金淋巴瘤 | B-非霍奇金淋巴瘤 | B-前体 ALL美国
-
National Cancer Institute (NCI)邀请报名
-
National Cancer Institute (NCI)完全的
-
GlaxoSmithKline终止
-
National Cancer Institute (NCI)完全的淋巴瘤,B细胞 | 白血病,B细胞 | 淋巴瘤,霍奇金 | 淋巴瘤,非霍奇金美国
-
GlaxoSmithKline终止
-
Adaptimmune主动,不招人肿瘤美国, 加拿大, 西班牙, 英国, 荷兰, 法国, 意大利
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Institutes of Health (NIH)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.; The V Foundation for Cancer Research主动,不招人
-
University of FloridaAccelerate Brain Cancer Cure; Lyla Nsouli Foundation主动,不招人
-
Technical University of Munich完全的
-
University of FloridaNational Cancer Institute (NCI); National Institutes of Health (NIH); National Pediatric Cancer... 和其他合作者主动,不招人
-
University Hospital, Basel, SwitzerlandGMP network of Basel完全的
-
Nkarta Inc.主动,不招人
-
National Cancer Institute (NCI)暂停
-
Richard WuIovance Biotherapeutics, Inc.主动,不招人局部晚期黑色素瘤 | IV 期黑色素瘤 | 病理 IIIB 期皮肤黑色素瘤 AJCC v8 | 病理学阶段 IIIC 皮肤黑色素瘤 AJCC v8 | 病理IIID期皮肤黑色素瘤AJCC v8美国
-
GlaxoSmithKlineMerck Sharp & Dohme LLC终止
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Iovance Biotherapeutics, Inc.主动,不招人
-
Weill Medical College of Cornell UniversityNew York Blood Center终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Prometheus Laboratories; Key Biologics, LLC; Adelson Medical Research主动,不招人
-
Immatics US, Inc.完全的
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
Leiden UniversityBristol-Myers Squibb主动,不招人
-
Myeloid Therapeutics暂停
-
National Institute of Neurological Disorders and...完全的
-
National Cancer Institute (NCI)终止
-
GlaxoSmithKline主动,不招人